Counterforce Health (Page 119)

More issues

The Requirements Checklist to Get Ultomiris (ravulizumab) Covered by UnitedHealthcare in Illinois: Complete PA Guide

Answer Box: Getting Ultomiris Covered by UnitedHealthcare in Illinois Fastest path to approval: Submit prior authorization through UnitedHealthcare Provider Portal with complete clinical documentation showing FDA-approved indication (PNH, aHUS, gMG, or NMOSD), meningococcal vaccination records, and step therapy exception if bypassing eculizumab. In Illinois, you have strong appeal rights including

Getting Stelara (Ustekinumab) Covered by Humana in Pennsylvania: Complete 2025 Guide to Prior Authorization and Appeals

Quick Answer: Your Path to Stelara Coverage Humana Medicare Advantage typically requires prior authorization for Stelara (ustekinumab), with step therapy often required for psoriasis, Crohn's disease, and psoriatic arthritis. IV induction is covered under Part B; maintenance injections under Part D through specialty pharmacy. If denied, Pennsylvania'

How to Get Busulfex (busulfan injection) Approved by Humana in Virginia: Prior Authorization Guide with Forms and Appeals

Answer Box: Fastest Path to Approval For Virginia Humana members: Busulfex (busulfan injection) requires prior authorization under your medical benefit for transplant conditioning. Start today: (1) Have your transplant center complete Humana's professionally administered drug PA form, (2) submit via provider portal with detailed transplant protocol and CML

How to Get Tracleer (bosentan) Covered by Aetna (CVS Health) in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tracleer (bosentan) Covered by Aetna (CVS Health) in New York Aetna (CVS Health) requires prior authorization and typically step therapy for Tracleer (bosentan), treating it as a non-formulary specialty drug. Success requires: 1) Complete Bosentan REMS enrollment for both prescriber and patient, 2) Document failure/intolerance of

Do You Qualify for Pyrukynd (mitapivat) Coverage by Cigna in Illinois? Decision Tree & Next Steps

Answer Box: Your Path to Pyrukynd Coverage Yes, you can get Pyrukynd (mitapivat) covered by Cigna in Illinois if you meet genetic and clinical criteria. Cigna requires: (1) age 18+, (2) confirmed PKLR gene variants (≥2 variants with ≥1 missense), (3) hemoglobin ≤10 g/dL or significant transfusion history, and

Getting Berinert (C1-Esterase Inhibitor) Covered by Aetna CVS Health in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: How to Get Berinert Covered by Aetna CVS Health in Georgia Aetna requires prior authorization for Berinert (C1-esterase inhibitor, IV) with specific medical necessity criteria. To get approval: 1) Submit PA through Aetna's electronic portal with HAE diagnosis confirmation (low C4, abnormal C1-INH), 2) Include specialist

How to Get Oxlumo (lumasiran) Covered by UnitedHealthcare in Florida: Complete Guide with Forms, Appeals, and Timelines

Answer Box: UnitedHealthcare requires prior authorization for Oxlumo (lumasiran) in Florida, with approval typically requiring: (1) confirmed PH1 diagnosis via AGXT genetic testing, (2) specialist prescriber (nephrologist/geneticist), (3) elevated urinary oxalate levels, and (4) eGFR ≥30 mL/min/1.73 m². First step today: Have your nephrologist or geneticist

Get Tremfya (Guselkumab) Covered by Blue Cross Blue Shield in California: Prior Authorization Forms, Appeals, and Success Strategies

Answer Box: Fastest Path to Tremfya Approval Tremfya (guselkumab) requires prior authorization from Blue Cross Blue Shield in California for plaque psoriasis and psoriatic arthritis. First step: Have your dermatologist/rheumatologist complete TB screening and document prior therapy failures. Submit PA via fax (888-697-8122) or CoverMyMeds ePA. Standard approval takes

How to Get Hetlioz (tasimelteon) Covered by Blue Cross Blue Shield Illinois: Complete Prior Authorization Guide

Quick Answer: Getting Hetlioz Covered by Blue Cross Blue Shield Illinois Blue Cross Blue Shield of Illinois (BCBSIL) requires prior authorization for Hetlioz (tasimelteon), administered through Prime Therapeutics. Success requires documenting an approved diagnosis (Non-24-hour sleep-wake disorder or Smith-Magenis syndrome), failed trials of preferred sleep medications, and specialist involvement. If

Getting Zanzalintinib (XL092) [investigational] Covered by Humana in New York: Clinical Trial Access and Compassionate Use Pathways

Answer Box: Your Fastest Path to Zanzalintinib (XL092) Access Zanzalintinib is investigational—Humana won't cover it as a standard drug. Your three pathways: 1) Clinical trials (search ClinicalTrials.gov for "XL092" or "zanzalintinib"), 2) Exelixis Expanded Access Program (free drug, insurance covers routine care)